AMARIN CORPORATION PLC - AMERICAN DEPOSITARY SHARE

NetDania - New 12 months Low: AMARIN CORPORATION PLC - AMERICAN DEPOSITARY SHARE

02 Aug 2024 09:48:41 By NetDania Notify

NetDania - New 12 months Low: AMARIN CORPORATION PLC - AMERICAN DEPOSITARY SHARE

01 Aug 2024 15:18:21 By NetDania Notify

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update

31 Jul 2024 07:00:01 By Nasdaq GlobeNewswire

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal

17 Jul 2024 16:15:00 By Nasdaq GlobeNewswire

Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024

17 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)

08 Jul 2024 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AMARIN CORPORATION PLC - AMERICAN DEPOSITARY SHARE

10 Jun 2024 15:19:27 By NetDania Notify

Amarin Board of Directors Announces CEO Transition

04 Jun 2024 07:30:00 By Nasdaq GlobeNewswire

 Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.

28 May 2024 08:15:23 By Nasdaq GlobeNewswire

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

06 May 2024 08:00:00 By Nasdaq GlobeNewswire

 Amarin Reports First Quarter 2024 Business Update and Financial Results

01 May 2024 07:00:00 By Nasdaq GlobeNewswire

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

24 Apr 2024 14:00:01 By Nasdaq GlobeNewswire

Amarin Announces Results of Annual General Meeting of Shareholders

22 Apr 2024 08:00:25 By Nasdaq GlobeNewswire

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

15 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

08 Apr 2024 08:00:01 By Nasdaq GlobeNewswire

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

06 Apr 2024 15:30:00 By Nasdaq GlobeNewswire

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

03 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

25 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024

15 Feb 2024 08:00:00 By Nasdaq GlobeNewswire